AYTU BIOPHARMA, INC Increase (Decrease) in Interest Payable, Net
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Interest Payable, Net of $0 for the 12-month period ending 2020-06-30, per its 10-K filed 2020-10-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2020-10-06
- AYTU BIOPHARMA, INC increase (decrease) in interest payable, net for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in interest payable, net for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in interest payable, net for the quarter ending 2019-06-30 was $31.87K.
- AYTU BIOPHARMA, INC increase (decrease) in interest payable, net for the quarter ending 2019-03-31 was $98.63K.
- AYTU BIOPHARMA, INC increase (decrease) in interest payable, net for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AYTU BIOPHARMA, INC increase (decrease) in interest payable, net for fiscal 2019 was $166.67K.
- AYTU BIOPHARMA, INC increase (decrease) in interest payable, net for fiscal 2018 was $0.00.
- AYTU BIOPHARMA, INC increase (decrease) in interest payable, net for fiscal 2015 was -$46.00K, a 200.00% decline from fiscal 2014.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $0.00 derived: sum of 2 quarters · filed 2020-10-06 | $0.00 10-K · filed 2020-10-06 | |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $0.00 10-Q · filed 2020-05-15 | ||
| 2019-12-31 | $0.00 10-Q · filed 2020-02-14 | |||
| 2019-06-30 | $31.87K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $130.50K derived: sum of 2 quarters · filed 2020-10-06 | $166.67K 10-K · filed 2020-10-06 | |
| 2019-03-31 | $98.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $134.79K 10-Q · filed 2020-05-15 | ||
| 2018-12-31 | $36.16K 10-Q · filed 2020-02-14 | |||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $0.00 derived: sum of 2 quarters · filed 2019-09-26 | $0.00 10-K · filed 2019-09-26 | |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | $0.00 10-Q · filed 2019-05-14 | ||
| 2017-12-31 | $0.00 10-Q · filed 2019-05-14 | |||
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2017-05-11 | $0.00 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $0.00 10-Q · filed 2017-02-09 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 | |||
| 2016-03-31 | $46.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $151.30K derived: sum of 2 quarters · filed 2017-05-11 | $208.94K 10-Q · filed 2017-05-11 | $205.61K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $104.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $161.99K 10-Q · filed 2017-02-09 | $158.66K derived: sum of 3 quarters · filed 2017-02-09 | $41.05K derived: sum of 4 quarters · filed 2017-02-09 |
| 2015-09-30 | $57.64K 10-Q · filed 2016-11-07 | $54.31K derived: sum of 2 quarters · filed 2016-11-07 | -$63.30K derived: sum of 3 quarters · filed 2016-11-07 | |
| 2015-06-30 | -$3.33K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | -$120.94K derived: sum of 2 quarters · filed 2016-05-11 | -$46.00K 10-K · filed 2015-09-28 | |
| 2015-03-31 | -$117.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | -$42.67K 10-Q · filed 2016-05-11 | ||
| 2014-12-31 | $74.94K 10-Q · filed 2016-02-11 | |||
| 2014-06-30 | $33.97K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $46.00K 10-K · filed 2015-09-28 | ||
| 2014-03-31 | $12.03K 10-Q · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |